US EditionFDA Wants Safer Cancer Drugs, But Some Startups Fear Unintended Consequences
Summary by Wall Street Journal
3 Articles
3 Articles
Wall Street Journal+2 Reposted by 2 other sources
FDA Wants Safer Cancer Drugs, But Some Startups Fear Unintended Consequences
For decades cancer drugmakers have taken a more-is-more model when dosing drugs in clinical trials. U.S. regulators want them to reconsider that approach.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
